HPM Partners LLC reduced its stake in shares of Danaher Co. (NYSE:DHR) by 1.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 78,483 shares of the conglomerate’s stock after selling 1,516 shares during the quarter. HPM Partners LLC’s holdings in Danaher were worth $7,285,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Stone Ridge Asset Management LLC acquired a new stake in Danaher during the 4th quarter worth about $470,000. Kendall Capital Management acquired a new stake in Danaher during the 4th quarter worth about $368,000. Guggenheim Capital LLC grew its position in Danaher by 0.9% during the 4th quarter. Guggenheim Capital LLC now owns 880,069 shares of the conglomerate’s stock worth $81,686,000 after purchasing an additional 7,641 shares during the period. QS Investors LLC grew its position in Danaher by 3.0% during the 4th quarter. QS Investors LLC now owns 28,849 shares of the conglomerate’s stock worth $2,678,000 after purchasing an additional 851 shares during the period. Finally, Clearbridge Investments LLC grew its position in Danaher by 0.7% during the 4th quarter. Clearbridge Investments LLC now owns 112,346 shares of the conglomerate’s stock worth $10,428,000 after purchasing an additional 774 shares during the period. 76.83% of the stock is currently owned by institutional investors.
Shares of Danaher Co. (DHR) opened at $103.74 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.39. Danaher Co. has a twelve month low of $78.97 and a twelve month high of $104.82. The stock has a market capitalization of $72,365.80, a PE ratio of 29.39, a P/E/G ratio of 2.18 and a beta of 1.03.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Thursday, March 29th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 0.62%. This is a boost from Danaher’s previous quarterly dividend of $0.14. The ex-dividend date is Wednesday, March 28th. Danaher’s payout ratio is presently 15.86%.
In related news, CFO Daniel L. Comas sold 62,989 shares of Danaher stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $101.96, for a total value of $6,422,358.44. Following the sale, the chief financial officer now directly owns 227,805 shares in the company, valued at approximately $23,226,997.80. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP William K. Daniel sold 131,066 shares of the firm’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $102.05, for a total transaction of $13,375,285.30. Following the completion of the transaction, the executive vice president now directly owns 270,523 shares in the company, valued at $27,606,872.15. The disclosure for this sale can be found here. Over the last quarter, insiders sold 313,260 shares of company stock worth $31,657,786. 12.20% of the stock is currently owned by insiders.
Several equities research analysts have weighed in on DHR shares. Stifel Nicolaus increased their price target on Danaher from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Wednesday, January 31st. Cowen reaffirmed a “buy” rating and set a $110.00 price target on shares of Danaher in a research report on Tuesday, January 30th. UBS Group initiated coverage on Danaher in a research report on Monday, January 22nd. They set a “buy” rating and a $99.97 price target on the stock. Robert W. Baird restated a “buy” rating on shares of Danaher in a research report on Friday, January 12th. Finally, Citigroup raised their target price on Danaher to $107.00 and gave the company a “buy” rating in a research report on Friday, December 15th. One analyst has rated the stock with a sell rating, six have issued a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $101.23.
COPYRIGHT VIOLATION NOTICE: “HPM Partners LLC Has $7.29 Million Holdings in Danaher Co. (DHR)” was reported by Markets Daily and is owned by of Markets Daily. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.themarketsdaily.com/2018/03/11/hpm-partners-llc-has-7-29-million-holdings-in-danaher-co-dhr.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.